Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.38 |
| ▸ | UBE2M | P61081 | 2/20 | 0.37 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | JAK1 | P23458 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | BACE1 | P56817 | 2/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17907952 | 0.88 | ALDH1A1 (0.41) | PTGDR2GRIN2B | |
| SCHEMBL17907957 | 0.83 | CYP2D6 (0.42) | PTGDR2GRIN2B | |
| SCHEMBL17907987 | 0.82 | GRIN2B (0.41) | PTGDR2GRIN2BJAK2JAK1 | |
| SCHEMBL17907982 | 0.82 | GRIN2B (0.44) | PTGDR2GRIN2BJAK2JAK1 | |
| SCHEMBL17908006 | 0.81 | NOS3 (0.41) | PTGDR2GRIN2B | |
| SCHEMBL17907936 | 0.80 | GRIN2B (0.39) | PTGDR2GRIN2BJAK2JAK1 | |
| SCHEMBL17907961 | 0.78 | BCHE (0.53) | SCN9ACHRM4GRIN2BBCHEACHE | |
| SCHEMBL17907929 | 0.77 | CYP2D6 (0.42) | PTGDR2GRIN2B | |
| SCHEMBL17907974 | 0.75 | NOS3 (0.41) | PTGDR2GRIN2B | |
| SCHEMBL17907994 | 0.75 | PTGDR2 (0.51) | PTGDR2SCN9ACHRM4UBE2MDCUN1D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2697223-B1 | 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS | ACTELION PHARMACEUTICALS LTD (CH) | 2016-07-13 | — | — | EP | disclosed |